Advertisement

Topics

Nexia Biotechnologies Incorporated Company Profile

18:57 EST 17th February 2018 | BioPortfolio

Nexia Biotechnologies is one of the world's largest producers of authentic recombinant spider silk, and a leading North American animal transgenic company. Nexia manufactures biomaterials and therapeutic proteins in the milk of transgenic dairy goats. This technology combines the large scale, cost-effective dairy infrastructure with recombinant DNA technology to produce rare, complex proteins.

Location

21 111 Lakeshore Road PO Box 183
Sainte Anne-de-Bellevue
Quebec
H9X 3V9
Canada

Contact

Fax: 450 424 7465
Email: hr@nexiabiotech.com


News Articles [88 Associated News Articles listed on BioPortfolio]

CES 2018: Nexia Introduces Innovative New Features, Products to Further Enhance Consumers' ...

RoomIQ by Nexia, a feature for Trane and American Standard Heating, Ventilation, and Air Conditioning (HVAC) comfort systems, will use the system's Nexia-enabled thermostat Read more...

#jobs #lifescience FUJIFILM Diosynth Biotechnologies: Principal Scientist (Analytical Development) x 2

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: FUJIFILM Diosynth Biotechnologies: Principal Scientist (Analytical Developmen...

Fujifilm Diosynth Biotechnologies opens new UK lab

Fujifilm Diosynth Biotechnologies has opened a $9m process development laboratory in Teeside, UK.

Adaptive Biotechnologies kündigt Kooperation mit Amgen für den Fortschritt der klinischen Entwicklung des clonoSEQ-Assays bei Multiplem Myelom an

Adaptive Biotechnologies, eines der führenden Unternehmen für die Kombination von Sequenzierung der nächsten Generation (Next-Generation Sequencing, NGS) und durchdachter Bioinformatik für die Pro...

Elanix Biotechnologies: Erfolgreiche Studie

Transwell Biotech, ein Partner von Elanix Biotechnologies, schließt eine Phase-I Studie zur Wundbehandlung bei Hauttransplantaten ab. Das Produkt von Transwell kombiniert ein Hydrogel mit kryokonse.....

Ethrog Biotechnologies Invitrogen iBlot Dry Blotting Gel Transfer System +Manual

$59.99End Date: Thursday Dec-7-2017 11:05:38 PSTBuy It Now for only: $59.99Buy It Now | Add to watch list Biotech365 : Ethrog Biotechnologies Invitrogen iBlot Dry Blotting Gel Transfer System +Ma...

Elanix Biotechnologies: Neues zur Kapitalerhöhung

Bei Elanix Biotechnologies steht eine Kapitalerhöhung an. Ausgegeben werden fast 1,7 Millionen neue Aktien. Aktionäre können die Papiere im Verhältnis 4:1 zeichnen. Für vier alte Aktien wird es e...

Azelis and Tagra Biotechnologies Extend Partnership

Israel’s Tagra Biotechnologies has appointed Azelis as the exclusive distributor of its range of Release on Demand (RND) microcapsules for all personal care applications in France and Benelux, w...

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

Ethical principles for the use of human cellular biotechnologies.

Rebooting Bioresilience: A Multi-OMICS Approach to Tackle Global Catastrophic Biological Risks and Next-Generation Biothreats.

Global Catastrophic Biological Risks (GCBRs) refer to biological events-natural, deliberate, and accidental-of a global and lasting impact. This challenges the life scientists to raise their game on t...

Is De-extinction Special?

I have been involved with the current interest in de-extinction since early 2012, nearly its beginning. I have given a lot of thought to the potential risks and benefits of de-extinction. But only rec...

Technologies for the bioconversion of methane into more valuable products.

Methane, with a global warming potential twenty five times higher than that of CO2 is the second most important greenhouse gas emitted nowadays. Its bioconversion into microbial molecules with a high ...

Overcoming the energetic limitations of syngas fermentation.

The fermentation of synthesis gas (including carbon monoxide, carbon dioxide, and hydrogen) with anaerobic acetogens is an established biotechnological process that has recently been transferred to a ...

Clinical Trials [0 Results]

None

Companies [141 Associated Companies listed on BioPortfolio]

Nexia Biotechnologies Incorporated

Nexia Biotechnologies is one of the world's largest producers of authentic recombinant spider silk, and a leading North American animal transgenic company. Nexia manufactures biomaterials and therapeu...

Nexia Biotechnologies Inc

Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and ...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Nexia Holdings, Inc.

Open Therapeutics

Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

More Information about "Nexia Biotechnologies Incorporated" on BioPortfolio

We have published hundreds of Nexia Biotechnologies Incorporated news stories on BioPortfolio along with dozens of Nexia Biotechnologies Incorporated Clinical Trials and PubMed Articles about Nexia Biotechnologies Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nexia Biotechnologies Incorporated Companies in our database. You can also find out about relevant Nexia Biotechnologies Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record